FDA proposes change in antimicrobials reporting

The new data collected would be used to help target its efforts to ensure judicious use of medically important antimicrobials.

The FDA is proposing revisions to its annual reporting requirements for drug sponsors of all antimicrobials sold, or distributed for use, in food-producing animals in order to obtain estimates of sales by major food-producing species.

The additional data would improve understanding about how antimicrobials are sold or distributed for use in major food-producing species and help the FDA further target its efforts to ensure judicious use of medically important antimicrobials.

The proposed rule also includes a provision to improve the timeliness of the report by requiring the FDA publish its annual summary report of antimicrobial sales and distribution information by Dec. 31 of the following year.

Current regulatory authority limits the data collection that FDA can mandate to antimicrobial sales and distribution information.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report